Back to search

National and Kapodistrian University of Athens

Ο ρόλος της διέγερσης των μιτοχονδριακών μυοκαρδιακών υποδοχέων βενζοδιαζεπίνης στο ΟΕΜ και τη βλάβη από επαναιμάτωση

Abstract

dc:description

Background: The Translocator Protein of the outer mitochondrial membrane has been recently recognized as a potential therapeutic target for the mitigation of ischemia/reperfusion injury in heart. A ligand of this receptor, 4-chlorodiazepam (4-CLD), increases cardiomyocyte resistance to oxidative stress, however, its role on endothelial cell integrity and recovery of myocardial function after ischemia has not been investigated. We examined the effects 4-CLD, administered at the onset of reperfusion, on the severity of microvascular damage and the recovery of systolic function in a rat model of ischemia-reperfusion.Methods: Acute myocardial infarction was induced in 32 (weight 300-350 gr) Wistar rats by ligation of the mid portion left anterior descending coronary artery for 45 minutes, followed by 1 hour of reperfusion. Five minutes before the onset of reperfusion the animals were randomly assigned (1:1) to either intraventricular infusion of 200 μL of 4-CLD (1%) or control. Infusion was performed during temporary obstruction (20sec) of the blood flow in the inferior vena cava and the ascending aorta sequentially, insuring the selective intracoronary delivery of the administered agent. At the end of reperfusion, animals were randomly reassigned (1:1 in each group) to either microvascular obstruction (MVΟ) and area at risk of the left ventricular myocardium (AR) planimetry [acute protocol] or to left ventricular end-diastolic (EDV) and end-systolic volumes (ESV) and ejection fraction (EF) at 2 and 60 days post-intervention measurements, as well as planimetry for infarct size calculation [chronic protocol].Results: Although the myocardial area at risk did not differ significantly between the 2 groups in the acute protocol (22.7 % ± 6.3% vs 21.4 % ± 6.3% p=0.695 for 4-CLD and control, respectively), there was a significant reduction of MVO in 4-CLD group, 15.1 % ± 5.6 % of the area at risk vs 23.5 % ± 8.3 % in the control group (p=0.034). EDV and ESV did not differ significantly between the two groups at 2 days post-MI echocardiography, whereas EF was significantly higher in the 4-CLD group compared to the control group (58 ± 9 vs 45 ± 8%, p=0.03). At 60 day ultrasound study, cardiac volumes were significantly higher in the control group when compared to the 4-CLD group (EDV: 432 ± 102 ml vs 273 ± 120 ml, p=0.045, LVESD: 198 ± 98 ml vs 95 ± 45 ml, p=0.003). LV systolic function recovered in both groups but remained significantly higher in the 4-CLD group (66 ± 8% vs 49 ± 11%, p=0.018). Planimetry at 60 days demonstrated significant reduction of infarct size in the 4-CLD compared with the control group (11.4 ± 4.1% of the LV vs. 17.3 ± 2.5 % of the LV, p=0.025).Conclusions: In an experimental model of myocardial ischemia/reperfusion, intracoronary administration of 4-CLD just before the onset of reperfusion reduces the extent of the no-reflow phenomenon and leads to early and sustained enhancement of LV systolic function and reduction of the LV infarct size.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kapelios, Chris
  • Καπέλιος, Χρήστος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/39614

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kapelios, Chris; Καπέλιος, Χρήστος. Ο ρόλος της διέγερσης των μιτοχονδριακών μυοκαρδιακών υποδοχέων βενζοδιαζεπίνης στο ΟΕΜ και τη βλάβη από επαναιμάτωση. National and Kapodistrian University of Athens, 2016. http://hdl.handle.net/10442/hedi/39614